These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16678543)

  • 1. Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs.
    Lee YS; Kim H; Wu TX; Wang XM; Dionne RA
    Clin Pharmacol Ther; 2006 May; 79(5):407-18. PubMed ID: 16678543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial.
    Morrison BW; Christensen S; Yuan W; Brown J; Amlani S; Seidenberg B
    Clin Ther; 1999 Jun; 21(6):943-53. PubMed ID: 10440619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial.
    Malmstrom K; Daniels S; Kotey P; Seidenberg BC; Desjardins PJ
    Clin Ther; 1999 Oct; 21(10):1653-63. PubMed ID: 10566562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
    Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
    Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential effects of bupivacaine and lidocaine on prostaglandin E2 release, cyclooxygenase gene expression and pain in a clinical pain model.
    Gordon SM; Chuang BP; Wang XM; Hamza MA; Rowan JS; Brahim JS; Dionne RA
    Anesth Analg; 2008 Jan; 106(1):321-7, table of contents. PubMed ID: 18165598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans.
    Schwartz JI; Chan CC; Mukhopadhyay S; McBride KJ; Jones TM; Adcock S; Moritz C; Hedges J; Grasing K; Dobratz D; Cohen RA; Davidson MH; Bachmann KA; Gertz BJ
    Clin Pharmacol Ther; 1999 Jun; 65(6):653-60. PubMed ID: 10391671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model.
    Ehrich EW; Dallob A; De Lepeleire I; Van Hecken A; Riendeau D; Yuan W; Porras A; Wittreich J; Seibold JR; De Schepper P; Mehlisch DR; Gertz BJ
    Clin Pharmacol Ther; 1999 Mar; 65(3):336-47. PubMed ID: 10096266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of prophylactic use of rofecoxib in comparison with ibuprofen on postendodontic pain.
    Gopikrishna V; Parameswaran A
    J Endod; 2003 Jan; 29(1):62-4. PubMed ID: 12540224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.
    Skarke C; Reus M; Schmidt R; Grundei I; Schuss P; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2006 Dec; 80(6):621-32. PubMed ID: 17178263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model.
    Khan AA; Brahim JS; Rowan JS; Dionne RA
    Clin Pharmacol Ther; 2002 Jul; 72(1):44-9. PubMed ID: 12152003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of cyclooxygenases.
    Agúndez JA; Blanca M; Cornejo-García JA; García-Martín E
    Pharmacogenomics; 2015; 16(5):501-22. PubMed ID: 25916522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oral rofecoxib versus intravenous ketoprofen as an adjuvant to PCA morphine after urologic surgery.
    Cabrera MC; Schmied S; Derderian T; White PF; Vega R; Santelices E; Verdugo F
    Acta Anaesthesiol Scand; 2004 Oct; 48(9):1190-3. PubMed ID: 15352968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of preoperative oral rofecoxib in pain control for third molar surgery.
    Chiu WK; Cheung LK
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jun; 99(6):e47-53. PubMed ID: 15897845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining paracetamol with a selective cyclooxygenase-2 inhibitor for acute pain relief after third molar surgery: a randomized, double-blind, placebo-controlled study.
    Haglund B; von Bültzingslöwen I
    Eur J Oral Sci; 2006 Aug; 114(4):293-301. PubMed ID: 16911100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors.
    Wang XM; Wu TX; Lee YS; Dionne RA
    Clin Pharmacol Ther; 2006 Apr; 79(4):303-15. PubMed ID: 16580899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
    Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
    Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis.
    Reding T; Bimmler D; Perren A; Sun LK; Fortunato F; Storni F; Graf R
    Gut; 2006 Aug; 55(8):1165-73. PubMed ID: 16322109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F; Michaud K; Burke TA; Zhao SZ
    J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of adjunctive use of rofecoxib versus ibuprofen in the management of postoperative pain after uterine artery embolization.
    Hovsepian DM; Mandava A; Pilgram TK; Holder AP; Wong V; Chan P; Patel T
    J Vasc Interv Radiol; 2006 Apr; 17(4):665-70. PubMed ID: 16614150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does perioperative administration of rofecoxib improve analgesia after spine, breast and orthopaedic surgery?
    Riest G; Peters J; Weiss M; Pospiech J; Hoffmann O; Neuhäuser M; Beiderlinden M; Eikermann M
    Eur J Anaesthesiol; 2006 Mar; 23(3):219-26. PubMed ID: 16430794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.